Evidence map›Paper›PMID 42006941›Full record

ArticleInfection prevention in practice2026

Risk and prognosis of infection and colonisation by carbapenemase-producing

Lukas Holm Saarup, Kasper Vium Andersen, Kirstine Kobberøe Søgaard, Regitze Gyldenholm Skals, Kristoffer Koch, Nina Ank, Samuel Azuz, Paw Jensen, Mogens Tornby Stender, Anette M Hammerum and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection prevention in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lukas Holm SaarupDepartment of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark.
Kasper Vium AndersenDepartment of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark.
Kirstine Kobberøe SøgaardDepartment of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark.
Regitze Gyldenholm SkalsResearch Data and Biostatistics, Aalborg University Hospital, Aalborg, Denmark.
Kristoffer KochDepartment of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark.
Nina AnkDepartment of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark.
Samuel AzuzDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Paw JensenDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Mogens Tornby StenderDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Anette M HammerumThe National Reference Laboratory for Antimicrobial Resistance, Statens Serum Institut, Copenhagen, Denmark.
Henrik HasmanThe National Reference Laboratory for Antimicrobial Resistance, Statens Serum Institut, Copenhagen, Denmark.
Hans Linde NielsenDepartment of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Since October 2012, New Delhi metallo-beta-lactamase (NDM)-1-producing Methods: We conducted a matched case-control and cohort study (2012-2023). Cases were patients with ST18 NDM-1-producing Results: Sixty-nine cases and 552 controls were included. The strongest risk factors were prolonged hospital stay (>14 vs ≤7 days; odds ratio [OR]=6.4, 95% confidence interval [CI]= 3.6-11.3), peritoneal disease (OR=4.4, 95% CI= 1.5-13.3), pancreatobiliary disorders (OR=5.5, 95% CI= 3.0-10.3), biliary tract surgery (OR=4.6, 95% CI= 2.7-7.8), pancreatic surgery (OR=4.4, 95% CI= 2.2-8.6), and in-hospital exposure to vancomycin (OR=13.9, 95% CI= 6.8-28.4), beta-lactam/beta-lactamase inhibitors (OR=8.8, 95% CI= 4.2-18.2), fluoroquinolones (OR=8.2, 95% CI= 4.6-14.9), or systemic antifungals (OR=8.6, 95% CI= 4.7-15.6). Thirty-day mortality was higher among cases (adjusted HR=2.2, 95% CI= 1.1-4.3), while 90- and 365-day mortality did not differ. Conclusion: Infection or colonisation with ST18 NDM-1-producing

Indexed as

CarbapenemaseCase–control studiesCitrobacter freundiiDisease transmissionNew Delhi metallo-beta-lactamase 1Risk factors

Identifiers

PMID42006941
PMCPMC13085058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.